Juvenal Tobin W 4
4 · CASTLE BIOSCIENCES INC · Filed Nov 24, 2025
Insider Transaction Report
Form 4
Juvenal Tobin W
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-20$3.38/sh+4,693$15,862→ 89,288 total - Sale
Common Stock
2025-11-20$35.58/sh−4,693$166,977→ 84,595 total - Exercise/Conversion
Stock option (right to buy)
2025-11-20−4,693→ 11,210 totalExercise: $3.38Exp: 2029-03-12→ Common Stock (4,693 underlying)
Holdings
- 2,230(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 11, 2024.
- [F2]Reflects an adjustment of 68 shares to the number of shares beneficially owned following a reconciliation of the Reporting Person's records.
- [F3]This transaction was executed in multiple trades at prices ranging from $35.40 to $35.85, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]Held by Tobin W and Susan M Juvenal Family Revocable Trust of which the Reporting Person and his spouse are the trustees and the Reporting Person, his spouse and their children are the beneficiaries.
- [F5]The shares subject to the option are fully vested.